
FDA Approves Skinvive by Juvéderm
FDA Approves Skinvive by Juvéderm (hyaluronic acid) Microdroplet Injection to Improve Skin Smoothness of the Cheeks IRVINE, Calif., May 15, 2023 /PRNewswire/ — Today, Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announced the U.S. FDA approval of Skinvive™ by Juvéderm® to improve skin smoothness of the cheeks in adults over the age of 21.1 Skinvive™ by Juvéderm® is the first […]
Read more